| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, Pennsylvania and 2 Instituto Europeo di Oncologia, Milan, Italy
Requests for reprints: Anthony J. Capobianco, Molecular and Cellular Oncogenesis Program, Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. Phone: 215-495-6816; Fax: 215-495-6819; E-mail: acapobianco{at}wistar.org.
Misregulation of the Wnt signaling pathway has been linked to many human cancers including colon carcinoma and melanoma. The primary mediator of the oncogenic effects of the Wnt signaling pathway is ß-catenin. Accumulation of nuclear ß-catenin and transcription activation of lymphoid enhancer factor 1 (LEF1)/T-cell factor (TCF) target genes underlie the oncogenic activity. However, the mechanism of ß-catenin–mediated transcriptional activation remains poorly understood. In this study, we identified Mastermind-like 1 (Maml1), which is thought to be a specific coactivator for the Notch pathway, as a coactivator for ß-catenin. We found that Maml1 participates in the Wnt signaling by modulating the ß-catenin/TCF activity. We show in vivo that Maml1 is recruited by ß-catenin on the cyclin D1 and c-Myc promoters. Importantly, we show that Maml1 functions in the Wnt/ß-catenin pathway independently of Notch signaling. Finally, we show that the knockdown of Mastermind-like family proteins in colonic carcinoma cells results in cell death by affecting ß-catenin–induced expression of cyclin D1 and c-Myc. This is the first demonstration of a role for the Mastermind-like family in another signaling pathway and that the knockdown of Mastermind-like family function leads to tumor cell death. [Cancer Res 2007;67(18):8690–8]
This article has been cited by other articles:
![]() |
M. L. Hansson, A. E. Popko-Scibor, M. Saint Just Ribeiro, B. M. Dancy, M. J. Lindberg, P. A. Cole, and A. E. Wallberg The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity Nucleic Acids Res., May 1, 2009; 37(9): 2996 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rodilla, A. Villanueva, A. Obrador-Hevia, A. Robert-Moreno, V. Fernandez-Majada, A. Grilli, N. Lopez-Bigas, N. Bellora, M. M. Alba, F. Torres, et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer PNAS, April 14, 2009; 106(15): 6315 - 6320. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, T. Kagawa, T. Inoue, A. Nonaka, S. Takada, H. Aburatani, and T. Taga Stabilized {beta}-Catenin Functions through TCF/LEF Proteins and the Notch/RBP-J{kappa} Complex To Promote Proliferation and Suppress Differentiation of Neural Precursor Cells Mol. Cell. Biol., December 15, 2008; 28(24): 7427 - 7441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Kankel, G. D. Hurlbut, G. Upadhyay, V. Yajnik, B. Yedvobnick, and S. Artavanis-Tsakonas Investigating the Genetic Circuitry of Mastermind in Drosophila, a Notch Signal Effector Genetics, December 1, 2007; 177(4): 2493 - 2505. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |